BioUtah News
-
Merit Medical Launches Smallest and Shortest Configuration of Elation® Pulmonary Balloon Dilator to Help Meet Critical Patient Need
Only balloon configuration specifically designed to dilate small airways, providing minimally invasive treatment to patients with lung obstructions
-
Co-Diagnostics, Inc. to Announce Expansion of OEM Agreement with Bio Molecular Systems at AACC
Co-Diagnostics announced that it will be disclosing the global expansion of its OEM agreement with Bio Molecular Systems…
-
ARUP’s New Monkeypox Test Can Be Performed on More Specimen Types on High-Throughput Instruments
SALT LAKE CITY, July 25, 2022 — ARUP Laboratories today announced that it has begun in-house testing for…
-
Nexus Spine Announces Launch of Stable-C™ Cervical Interbody System with Integrated Fixation
Launch represents the company’s eighth commercial release within its line of Tranquil™ interbody fusion implants
-
Nomi Health Opens Infant and Pediatric COVID Vaccine Location
OREM, Utah–(BUSINESS WIRE)–Nomi Health, a direct healthcare company dedicated to improving access and lowering costs in the healthcare…
-
Nomi Health Acquires Everyone Health, Sano Surgery
As Americans continue to pay more for needed medical treatments and with care costs outpacing the rate of…
-
Co-Diagnostics, Inc. Announces Shipment of Monkeypox Virus Test
Co-Diagnostics announced that it has shipped testing reagents for monkeypox virus currently exhibiting a multi-country outbreak to one…
-
Biomerics Launches Interventional Medical Plastics Division with Acquisition of Dependable Plastics
Biomerics announced the acquisition of Dependable Plastics and creation of a new division — Biomerics Interventional Medical Plastics…
-
Senate Democrats Renew Plan for Drug Price Controls
Senate Democrats have renewed a push for drug pricing reforms, releasing on Wednesday proposed legislation along with a…
-
BD Names Rishi Grover as Chief Integrated Supply Chain Officer
FRANKLIN LAKES, N.J., July 5, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global…
-
Spectrum Wins Two Science & Technology Best of State Awards
Spectrum Solutions, LLC today announced it has been awarded two Utah Best of State Science & Technology Awards…
-
$10k Women’s Seed Grant Announced at Inaugural BioHive Women’s Event
On June 24, BioHive held their inaugural Women’s event sponsored by BD, BioMerieux, e4H Architects, Health Catalyst, Known…
-
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2022
LONDON and SALT LAKE CITY, June 30, 2022 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an…
-
Myriad Genetics Teams Up with Epic to Make Genetic Testing Accessible to More Patients with Electronic Health Record (EHR) Integration
Healthcare providers can easily order Myriad’s genetic tests for the more than 250 million patients within Epic’s network
-
U.S. Patent Office Grants New Patent Protection For Exoskeleton Focal-Force Angioplasty Platform
Transit Scientific achieved increased U.S. patent protection for their novel exoskeleton focal-force angioplasty technology using standard off-the-shelf peripheral…
-
One Utah Health Collaborative and Utah’s BioHive Community
Governor Cox has invited Utah’s life sciences industry to engage in a bold initiative called the “One Utah…
-
Tempus Announces Research Collaboration with Intermountain Healthcare to Advance Precision Oncology Research
Tempus, a leader in artificial intelligence and precision medicine, today announced a collaboration with Intermountain Healthcare, a Utah-based,…
-
KT Tape Names Jessica Klodnicki As New CEO
AMERICAN FORK, Utah, June 22, 2022 /PRNewswire/ — KT Tape®, the leader in drug-free pain relief products, today…
-
IONIQ Unveils LUNA3, Next-Generation Early-Stage Cancer Detection Platform
IONIQ Sciences unveiled its next-generation platform called LUNA3™ for early-stage cancer detection. LUNA3 is designed to accelerate the…
-
ATL Technology Acquires Developer of Disposable Scopes and Micro-Endoscopic Solutions, BioVision Technologies, LLC
Springville, Utah June 21, 2022—ATL Technology (“ATL”), a joint development manufacturing partner to top medical device firms, announced…
-
Utah RDAC Joins Juneteenth Health Fair
Members of the Utah Rare Disease Advisory Council (RDAC) on Monday participated in the Utah Juneteenth Holiday Health &…
-
Utah Life Sciences at BIO 2022
Utah’s life sciences industry left its mark on this week’s 2022 BIO International Convention at the San Diego…
-
CenExel Acquires Apex Innovative Sciences
Premier CNS-Focused Research Facilities in California and New Jersey Join the CenExel Centers of Excellence Clinical Research Site…
-
Sen. Romney Opposes Drug Importation as the Senate HELP Committee Advances User Fees
The Senate Health, Education, Labor and Pensions (HELP) Committee voted 13 to 9 on Tuesday to advance user…
-
Halia Therapeutics Announces First Participant Dosed in Phase 1 Clinical Study of HT-6184
HT-6184 is a novel NEK7/NLRP3 inhibitor
-
BD Collaborates with Mayo Clinic Platform, Leveraging Real-World Clinical Data to Improve Post-Market Device Surveillance, Drive Innovation for Patient Care
BD is among the first companies to enter innovative partnership with Mayo Clinic Platform for access to world’s…
-
University of Manchester Adds Carterra’s LSA® Instrument for High-Throughput Antibody Screening and Characterization
MANCHESTER, England & SALT LAKE CITY–(BUSINESS WIRE)–The University of Manchester, United Kingdom, and Carterra, Inc., the world leader…
-
Sumitomo Pharma Oncology Receives Orphan Drug Designation for TP-3654, an Investigational Oral Inhibitor of PIM Kinases for the Treatment of Myelofibrosis
CAMBRIDGE, Mass., June 8, 2022 /PRNewswire/ — Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer…
-
ELEVAR THERAPEUTICS SHARES RESULTS OF PHASE 2 RIVOCERANIB TRIAL IN PATIENTS WITH PROGRESSIVE RECURRENT OR METASTATIC ADENOID CYSTIC CARCINOMA
CHICAGO, June 06, 2022 — Elevar Therapeutics, Inc., a fully integrated biopharmaceutical company dedicated to elevating treatment experiences…
-
CerTest Biotec and BD Announce Collaboration on Molecular Diagnostic Test for Monkeypox
CerTest Biotec Uses the BD MAX™ Molecular Diagnostic System Open System Reagent Suite to Develop RT-PCR Detection Kit
-
BD TO ACQUIRE PARATA SYSTEMS TO ENTER NEW PHARMACY AUTOMATION SOLUTIONS MARKET
Expands BD Transformative Solutions to Provide New Pharmacy Automation Technologies for Hospitals, Retail Pharmacy, Long-Term Care and Home…
-
KidneyIntelX™ Demonstrates Ability to Assess Risk of Heart Failure Hospitalization and Death in Large International Diabetic Kidney Disease Patient Cohort
Data shared in oral presentation at American Diabetes Association 82nd Scientific Sessions® and published in Kidney360 highlights importance…
-
PolarityTE Announces $8.0 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules
PolarityTE announced that it has entered into securities purchase agreements with a single healthcare-focused institutional investor
-
Civica Selects Profil as Clinical Trial Partner for Affordable Insulin Initiative
Profil has conducted over 30 biosimilar insulin trials and is the leading clinical research organization for studies related…
-
Biomerics announces expansion in Ireland with a new facility in Galway
BIOMERICS ANNOUNCES EXPANSION INTO IRELAND Expanding High-Performance Balloon Design & Development Capabilities in Galway
-
Co-Diagnostics, Inc. Completes Principal Design of Test for Monkeypox Virus
Co-Diagnostics announced that it has completed the principal design work of a PCR test for the monkeypox virus…
-
Biomerics Announces Image Guided Intervention Division
SALT LAKE CITY, UTAH (Monday, May 2, 2022) – Biomerics, a leading vertically integrated contract manufacturer for the…
-
bioMérieux receives De Novo FDA Authorization for its BIOFIRE® Joint Infection (JI) Panel
Marcy l’Étoile, France – bioMérieux, a world leader in the field of in vitro diagnostics, today announces that its…
-
PolarityTE to Effectuate 1-for-25 Reverse Stock Split
PolarityTE announced that the Company will effectuate a 1-for-25 reverse stock split of the Company’s issued and outstanding…
-
PolarityTE Reports First Quarter 2022 Financial Results and Provides Business Update
PolarityTE provided a business update and reported financial results for the three-month period ended March 31, 2022.
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8M Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial…
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
